Lv1
48 积分 2024-02-26 加入
Bioinspired pH-Responsive Microalgal Hydrogels for Oral Insulin Delivery with Both Hypoglycemic and Insulin Sensitizing Effects
15小时前
已完结
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
5个月前
已完结
Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes
5个月前
已完结
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial
5个月前
已完结
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
6个月前
已完结
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes
6个月前
已完结
Fibroblast growth factor 2 decreases bleomycin‐induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation
8个月前
已完结
An update on peptide-based therapies for type 2 diabetes and obesity
8个月前
已完结
Safety of Semaglutide
8个月前
已完结
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
8个月前
已完结
皖公网安备34019202002308
